Tumor-secreted galectin-3 suppresses antitumor response by inducing IL-10<sup>+</sup> B cells

Gal-3 is a crucial regulator of immune evasion in BRCA. Targeting Gal-3 may improve the efficacy of BRCA therapies.

Authors

Zhenghao Wu (ORCID: https://orcid.org/0000-0001-8468-1234)
Wenhao Niu (ORCID: https://orcid.org/0000-0003-2797-9418)
Qianheng Wang (ORCID: https://orcid.org/0009-0000-5619-8384)
Tao Huang (ORCID: https://orcid.org/0000-0003-2130-8621)
Yibing Lv (ORCID: https://orcid.org/0000-0002-8768-4489)
Yunxiao Xiao
Meng Li (ORCID: https://orcid.org/0000-0001-6631-0819)
Jing Cao (ORCID: https://orcid.org/0009-0000-2161-8385)
Yirui Zhang (ORCID: https://orcid.org/0000-0002-0601-9496)
Junyi Xiao (ORCID: https://orcid.org/0000-0003-2000-5581)
Peng Zheng (ORCID: https://orcid.org/0009-0005-8072-6331)